How people with multiple sclerosis rate their quality of life: an EQ-5D survey via the UK MS register

Kerina H Jones, David V Ford, Philip A Jones, Ann John, Rodden M Middleton, Hazel Lockhart-Jones, Jeffrey Peng, Lisa A Osborne, J Gareth Noble, Kerina H Jones, David V Ford, Philip A Jones, Ann John, Rodden M Middleton, Hazel Lockhart-Jones, Jeffrey Peng, Lisa A Osborne, J Gareth Noble

Abstract

Introduction: The EQ-5D is a widely-used, standardised, quality of life measure producing health profiles, indices and states. The aims of this study were to assess the role of various factors in how people with Multiple Sclerosis rate their quality of life, based on responses to the EQ-5D received via the web portal of the UK MS Register.

Methods: The 4516 responses to the EQ-5D (between May 2011 and April 2012) were collated with basic demographic and descriptive MS data and the resulting dataset was analysed in SPSS (v.20).

Results: The mean health state for people with MS was 59.73 (SD 22.4, median 61), compared to the UK population mean of 82.48 (which is approximately 1SD above the cohort mean). The characteristics of respondents with high health states (at or above +1SD) were: better health profiles (most predictive dimension: Usual Activities), higher health indices, younger age, shorter durations of MS, female gender, relapsing-remitting MS, higher educational attainment and being in paid employment (all p-values<0.001). Conversely, the characteristics of respondents with low health states (at or below -1SD) were: poorer health profiles (most predictive dimension: Mobility), lower health indices, older age, longer durations of MS, male gender, progressive MS, lower educational attainment and having an employment status of sick/disabled (p = 0.0014 for age, all other p-values<0.001). Particular living arrangements were not associated with either the high or low health status groups.

Conclusions: This large-scale study has enabled in-depth analyses on how people with MS rate their quality of life, and it provides new knowledge on the various factors that contribute to their self-assessed health status. These findings demonstrate the impact of MS on quality of life, and they can be used to inform care provision and further research, to work towards enhancing the quality of life of people with MS.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exis.

Figures

Figure 1. Health profiles of the cohort…
Figure 1. Health profiles of the cohort of people with MS.
The frequencies of people with MS reporting no problems (level 1), some problems (level 2) and severe problems (level 3) on each of the 5 dimensions are indicated to show the health profiles of the cohort.

References

    1. Cheung K, Oemar M, Oppe M and Rabin R on behalf of the EuroQol group (2009) EQ-5D User Guide: basic information on how to use the EQ-5D, v2. Available: . Accessed 2013 February 20.
    1. EuroQol Group (1990) EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 16: 199–208.
    1. Kind P, Hardman G, Macran S (1999) UK population norms for EQ-5D, discussion paper 172, University of York. Available: . Accessed 2013 February 20.
    1. Multiple Sclerosis Society of Great Britain and Northern Ireland website. Available: . Accessed 2013 February 20.
    1. Ford DV, Jones KH, Middleton RM, Lockhart-Jones H, Maramba IDC, et al.. (2012) The feasibility of collecting information from people with Multiple Sclerosis for the UK MS Register via a web portal: characterising a cohort of people with MS. BMC Medical Informatics and Decision Making, 12(1), 73.
    1. Ford DV, Jones KH, Verplancke JP, Lyons RA, John G, et al. (2009) The SAIL Databank: building a national architecture for e-health research and evaluation. BMC Health Services Research 9(1): 157.
    1. Lyons RA, Jones KH, John G, Brooks CJ, Verplancke JP, et al. (2009) The SAIL databank: linking multiple health and social care datasets. BMC Medical Informatics and Decision Making 9(1): 3.
    1. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 67(6): 361–370.
    1. Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A (2001) The Multiple Sclerosis Impact Scale (MSIS-29). Brain 124(5): 962.
    1. Jones KH, Ford DV, Jones PA, John A, Middleton RM, et al. (2012) A Large-scale Study of Anxiety and Depression in People with Multiple Sclerosis: a Survey via the Web Portal of the UK MS Register. PLoS One 7(7): e41910 doi:
    1. Jones KH, Ford DV, Jones PA, John A, Middleton RM, et al. (2013) The physical and psychological impact of Multiple Sclerosis using the MSIS-29 via the web portal of the UK MS Register. PLoS One 8(1): e55422 doi:
    1. Szende A, Williams A (editors, on behalf of the EuroQol group) (2004) Measuring Self-Reported Population Health: An International Perspective based on EQ-5D. Available: . Accessed 2013 February 20.
    1. Sullivan PW, Slejko JF, Sculpher MJ, Ghushchyan V (2011) Catalogue of EQ-5D Scores for the United Kingdom. Medical Decision Making 2011 31: 800.
    1. National Research Ethics Service website. Ethical review of research databases. Available: . Accessed 2012 September 13.
    1. The UK MS Register website. Available: . Accessed 2013 February 20.
    1. Office for National Statistics. Nomis: official labour market statistics 2010–2011. Available: . Accessed 2012 September 13.
    1. Whitacre CC, Reingold SC, O'Looney PA, Blankenhorn E, Brinley F, et al.. (1999) A Gender Gap in Autoimmunity. Science, 26 February 1999: 283 (5406), 1277–1278.
    1. Juniper EF, Wisniewski ME, Cox FM, Emmett AH, Nielsen KE, et al. (2004) Relationship between quality of life and clinical status in asthma: a factor analysis. European Respiratory Journal 23: 287–291.
    1. Carr AJ, Gibson B, Robinson PG (2001) Is quality of life determined by expectations or experience? BMJ 322(7296): 1240–1243.
    1. Osborne LA, Bindemann N, Noble JG, Reed P (2012) Changes in the key areas of quality of life associated with age and time since diagnosis of long-term conditions. Chronic Illness 8(2): 112–120.
    1. Popham F, Gray L, Bambra C (2012) Employment status and the prevalence of poor self-rated health. Findings from UK individual-level repeated cross-sectional data from 1978 to 2004. BMJ Open 2: e001342 doi:
    1. Good A, Stokes S, Jerrams-Smith J (2007) Elderly, Novice Users and Health Information Websites: issues of accessibility and usability. Journal of Healthcare Information Management, 21 3: 72–79.
    1. Boot CLR, Frans JM (2010) The public and the Internet: Multifaceted drives for seeking health information. Health Informatics Journal 16: 145.
    1. Gallacher J, Collins R, Elliot P, Palmer S, Burton P, et al. (2013) A platform for the remote conduct of gene-environment interaction studies. PLoS One 8(1): e54331 doi:
    1. European Medicines Agency (2012) Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis, EMA/CHMP/771815/2011, Rev. Available: . Accessed 2012 September 2.
    1. Noble JG, Osborne LA, Jones KH, Middleton RM, Ford DV (2012) Commentary on “Disability Outcome Measures in Multiple Sclerosis Clinical Trials”. Multiple Sclerosis Journal. Volume 18 Issue 12.
    1. Osborne LA, Middleton RM, Jones KH, Ford DV, Noble JG (2013) Desirability and expectations of the UK MS Register: Views of people with MS. International Journal of Medical Informatics. (In press).
    1. Osborne LA, Noble JG, Lockhart-Jones H, Middleton RM, Thompson S, et al.. (2013) Identifying and addressing the barriers to the use of an internet-register for Multiple Sclerosis. International Journal of Healthcare Information Systems and Informatics, (in press).
    1. Osborne LA, Noble JG, Lockhart-Jones H, Middleton RM, Thompson S, et al. (2012) Sources of discovery, reasons for registration, and expectations of an internet-based register for Multiple Sclerosis: Visualisations and explorations of word uses and contexts. International Journal of Healthcare Information Systems and Informatics 7: 3.
    1. Hemmett L, Holmes J, Barnes M, Russell N (2004) What drives quality of life in multiple sclerosis? Q J Med 97: 671–676.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe